Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eprotirome Add-on to Statin in Dyslipidemia
NCT00593047Phase 2Completed
- Sponsor
- Karo Healthcare AB
- Start
- Nov 2007
- Primary completion
- Jul 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of eprotirome in dyslipidemia, hypercholesterolemia, sponsored by Karo Healthcare AB. Started Nov 2007; status: completed.
02
Drugs
eprotirome
03
Conditions
dyslipidemiahypercholesterolemia
Beyond the preview
Go deeper on NCT00593047.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00593047.